US health agency to crack down on risky stem cell offerings – The Philadelphia Tribune
The Philadelphia Tribune |
US health agency to crack down on risky stem cell offerings
The Philadelphia Tribune WASHINGTON — U.S. health authorities announced plans Thursday to crack down on doctors pushing stem cell procedures that pose the gravest risks to patients amid an effort to police a burgeoning medical field that previously has received little oversight. Modified blood stem cells reverse type 1 diabetes in mice Confronting unproven stem cell treatments in Australia: The new regulation A Spotlight on Global Stem Cell Therapy Market 2017-2022 Overview by Key Finding, Scope, Top Impacting Factors … |
